0001567619-20-011158.txt : 20200526 0001567619-20-011158.hdr.sgml : 20200526 20200526170653 ACCESSION NUMBER: 0001567619-20-011158 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20200526 DATE AS OF CHANGE: 20200526 EFFECTIVENESS DATE: 20200526 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Entos Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001812824 IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367695 FILM NUMBER: 20911621 BUSINESS ADDRESS: STREET 1: 2500-10220 103 AVE NW CITY: EDMONTON STATE: A0 ZIP: T5J 0K4 BUSINESS PHONE: 780-862-7445 MAIL ADDRESS: STREET 1: 2500-10220 103 AVE NW CITY: EDMONTON STATE: A0 ZIP: T5J 0K4 D 1 primary_doc.xml X0708 D LIVE 0001812824 Entos Pharmaceuticals Inc. 2500-10220 103 AVE NW EDMONTON A0 ALBERTA, CANADA T5J 0K4 780-862-7445 ALBERTA, CANADA None None Corporation true 2016 John Lewis c/o Entos Pharmaceuticals Inc. 2500-10220 103 Ave NW Edmonton A0 ALBERTA, CANADA T5J 0K4 Executive Officer Arun Raturi c/o Entos Pharmaceuticals Inc. 2500-10220 103 Ave NW Edmonton A0 ALBERTA, CANADA T5J 0K4 Executive Officer Roy Duncan c/o Entos Pharmaceuticals Inc. 2500-10220 103 Ave NW Edmonton A0 ALBERTA, CANADA T5J 0K4 Director Andries Zijlstra c/o Entos Pharmaceuticals Inc. 2500-10220 103 Ave NW Edmonton A0 ALBERTA, CANADA T5J 0K4 Director Pharmaceuticals Decline to Disclose 06c false 2020-05-11 false true true false 0 4000000 100000 3900000 false 1 0 0 0 false Entos Pharmaceuticals Inc. /s/ John Lewis John Lewis Chief Executive Officer 2020-05-26